stella
beta
Molecular Residual Disease Interception in Locoregionally-Advanced High Risk HPV+ and HPV- HNSCC — Stella
Recruiting
Back to Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC) trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
Canada
Princess Margaret Cancer Centre, Toronto
View full record on ClinicalTrials.gov